Compare FABC & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FABC | HSCS |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United States | United States |
| Employees | 108 | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4M | 15.8M |
| IPO Year | 1999 | 2022 |
| Metric | FABC | HSCS |
|---|---|---|
| Price | $1.65 | $2.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 95.0K | 92.6K |
| Earning Date | 11-24-2026 | 12-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.84 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,579,745.00 | $4,319.00 |
| Revenue This Year | N/A | $295.93 |
| Revenue Next Year | N/A | $18,321.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.43 | $1.63 |
| 52 Week High | $4.57 | $5.25 |
| Indicator | FABC | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 37.24 | 31.78 |
| Support Level | $1.43 | $1.84 |
| Resistance Level | $2.43 | $2.18 |
| Average True Range (ATR) | 0.19 | 0.35 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 24.42 | 3.50 |
Fabric.AI Inc is an infrastructure company building a suite of fabless semiconductor technologies to power AI factories - smart data centers optimized for producing intelligence at scale. The company's innovations include MicroLED-based optical interconnects and other system-critical technologies that enable faster, more efficient, and more scalable AI workloads. Its mission is to transform data centers into unified production systems for artificial intelligence.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.